Insulin Resistance & Metabolic Syndrome
We notice patterns early.
Small shifts in blood sugar.
Lipids slightly out of range.
Weight gathering differently.
Energy that doesn’t hold steady.
Not dramatic. Not always obvious.
But meaningful.
This is often how insulin resistance begins.
Left unaddressed, it can lead to metabolic syndrome. A combination of risk factors that increase the risk for diabetes, heart disease, and more.
These early signs deserve attention.
Explore your metabolic baseline
⁛
Explore your metabolic baseline ⁛
How Well Endocrinology approaches care
Metabolic syndrome signals increased risk for diabetes, heart disease, and chronic inflammation.
Care at Well Endocrinology begins with a full metabolic evaluation—going beyond basic labs to understand how the body is responding to insulin, managing lipids, and regulating inflammation.
The focus is on reducing long-term risk and protecting metabolic health over time.
The goal is to preserve insulin sensitivity, support cardiovascular function, and prevent progression to chronic disease.
This is precision medicine for longevity.
Metabolic Risk in South Asian Adults
Dr. Sadiq has a focused clinical interest in the metabolic health of South Asian patients.
Insulin resistance, type 2 diabetes, and cardiovascular disease often develop earlier—and at lower body weights—within this population. WHO guidelines now recommend using a BMI of 23 or higher to trigger screening, rather than the standard cutoff of 25, but these guidelines remain underused in most settings.
Sarcopenia—low muscle mass—is also more common and can worsen insulin resistance, even when overall weight is stable. These patterns are often overlooked in standard care.
Early recognition matters. So does education. Many South Asian patients don’t know that different cutoffs apply to them—or that they may need to ask for more specific testing.
It’s the right care, at the right time—before disease begins.
